Philip W. Loberg

2010

In 2010, Philip W. Loberg earned a total compensation of $703.4K as Executive Vice President, Interim Chief Financial Officer at Valeant Pharmaceuticals International.

Compensation breakdown

Non-Equity Incentive Plan$95,842
Option Awards$180,000
Salary$66,702
Stock Awards$356,400
Other$4,442
Total$703,386

Loberg received $356.4K in stock awards, accounting for 51% of the total pay in 2010.

Loberg also received $95.8K in non-equity incentive plan, $180K in option awards, $66.7K in salary and $4.4K in other compensation.

Rankings

In 2010, Philip W. Loberg's compensation ranked 6,534th out of 10,439 executives tracked by ExecPay. In other words, Loberg earned more than 37.4% of executives.

ClassificationRankingPercentile
All
6,534
out of 10,439
37th
Division
Manufacturing
2,368
out of 3,838
38th
Major group
Chemicals And Allied Products
535
out of 921
42nd
Industry group
Drugs
343
out of 680
50th
Industry
Pharmaceutical Preparations
258
out of 481
46th
Source: SEC filing on April 30, 2012.

Loberg's colleagues

We found eight more compensation records of executives who worked with Philip W. Loberg at Valeant Pharmaceuticals International in 2010.

2010

William Wells

Valeant Pharmaceuticals International

Chief Executive Officer

2010

Gilbert Godin

Valeant Pharmaceuticals International

Chief Operating Officer

2010

Margaret Mulligan

Valeant Pharmaceuticals International

Chief Financial Officer

2010

Gregory Gubitz

Valeant Pharmaceuticals International

General Counsel

2010

J Pearson

Valeant Pharmaceuticals International

Chief Executive Officer

2010

Rajiv De Silva

Valeant Pharmaceuticals International

Chief Operating Officer

2010

Robert Chai-Onn

Valeant Pharmaceuticals International

General Counsel

2010

Mark Durham

Valeant Pharmaceuticals International

Senior Vice President, Human Resources

You may also like